LEKAPHARM A/S: Financial statements 2014
CVR: 32945945
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
LEKAPHARM A/S (CVR 32945945) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 5,217,509 and a net result of DKK 1,590,630 compared with DKK 1,047,864 the year before. That is an increase of 16.4% compared with the year before. Equity in the 2014 report amounted to DKK 12,874,858. The solvency ratio was 79.2%.
- Gross Profit
- DKK 5,217,509
- Profit/Loss
- DKK 1,590,630
- Equity
- DKK 12,874,858
- Total Assets
- DKK 16,259,463
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 5.2 mio. | 1.6 mio. | 12.9 mio. | - |
| 2013 | - | 4.5 mio. | 1 mio. | 11.8 mio. | - |
| 2012 | - | - | - | - | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
LEKAPHARM A/S has published its annual report for 2013. Gross profit came to DKK 4,482,090, and the net result was DKK 1,047,864.
About LEKAPHARM A/S
LEKAPHARM A/S is a Danish company of the type Aktieselskab based in Kværndrup, founded in 2010. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Lasse Kjeldsen. The board consists of Susanne Frederiksen (chair), Emil Bødker Kjeldsen and Lasse Kjeldsen. The company is owned by LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS and Familien Kjeldsen Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 10,369,416 and a net result of DKK 5,517,066 compared with DKK 2,051,529 the year before. Equity in the 2025 report amounted to DKK 7,972,163.